| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Guangdong Taiantang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥0.27 |
| 52 Week High | CN¥3.35 |
| 52 Week Low | CN¥0.19 |
| Beta | -0.079 |
| 11 Month Change | -47.06% |
| 3 Month Change | -76.52% |
| 1 Year Change | -87.20% |
| 33 Year Change | -94.44% |
| 5 Year Change | -94.47% |
| Change since IPO | -97.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002433 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -6.9% | 1.0% | -1.4% |
| 1Y | -87.2% | -15.1% | -18.4% |
Return vs Industry: 002433 underperformed the CN Pharmaceuticals industry which returned -15.1% over the past year.
Return vs Market: 002433 underperformed the CN Market which returned -18.4% over the past year.
Price Volatility
| 002433 volatility | |
|---|---|
| 002433 Average Weekly Movement | 26.3% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 002433's share price has been volatile over the past 3 months.
Volatility Over Time: 002433's weekly volatility has increased from 13% to 26% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 677 | Shaobin Ke | www.tatonline.net |
Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patent medicines in China. It offers medicines in the form of creams, ointments, tablets, capsules, pills, and solutions for reproductive health, skin health, cardiovascular, cerebrovascular, dermatology, anti-inflammatory, and other areas. The company also engages in processing and trading Chinese medicinal materials; and pharmaceutical e-commerce business.
Guangdong Taiantang Pharmaceutical Co., Ltd. Fundamentals Summary
| 002433 fundamental statistics | |
|---|---|
| Market cap | CN¥207.03m |
| Earnings (TTM) | -CN¥2.20b |
| Revenue (TTM) | CN¥339.65m |
0.6x
P/S Ratio-0.1x
P/E RatioIs 002433 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002433 income statement (TTM) | |
|---|---|
| Revenue | CN¥339.65m |
| Cost of Revenue | CN¥1.48b |
| Gross Profit | -CN¥1.14b |
| Other Expenses | CN¥1.06b |
| Earnings | -CN¥2.20b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.87 |
| Gross Margin | -335.24% |
| Net Profit Margin | -648.74% |
| Debt/Equity Ratio | 229.3% |
How did 002433 perform over the long term?
See historical performance and comparison